Live Markets, Charts & Financial News

Treatment.com AI and Rocket Doctor CEO’s meet for a fireside chat to discuss the recently announced acquisition and the future of AI in healthcare

7

Article content

This news statement is not the distribution of the American New Zeo for publication services in the United States

Article content

Article content

Vancouver, British Colombia, February 20, 2025 (Globe Newswire) – Treatment.com Ai Inc. (CSE: True, OTC: Treif, Frankfurt: 939) (treatment)) I am pleased to recommend announcing it more than concluding an agreement to purchase final shares dated February 12, 2025 (“Final agreement“) To get rocking Doctor Inc. (“Rocket Doctor), Details in the press remedial statement on February 12, 2025 https://www.treatment.com/press/Treatment.com Ai and Rockket Doctor Inc have been combined to air chat to discuss more details and their chances.

Advertisement 2

Article content

It also covers the latest press release on February 19, 2025 https://www.treatment.com/Rocket-dockor-signs-Agreement-with-california- Manged-care-plan/

Dr. Asmam Hamza, CEO of AI and Dr. They discuss their views on how treatment therapy and Doctor's missiles have played a role in improving the health care sector positively and influencing current shortcomings and challenges.

https://www.treatment.com/wp-content

About Treatment.com AI Inc.

Treatment.com AI is a company that uses artificial intelligence (artificial intelligence) and best clinical practices to improve the health care sector positively and influence current shortcomings and challenges. With the inputs of hundreds of healthcare professionals in the world, Treatment.com AI built a comprehensive and personal career engine – World Medical Library (GLM). With more than 10,000 expert reviews, GLM provides clinical information tested and supported by all healthcare professionals in addition to providing recommended tests (physical and laboratory), and photography and filling symbols. GLM helps health care specialists (doctors, nurses or pharmacists) to reduce their administrative burden; It creates more time for patient appointments that have been needed to face; And enable more consistency in the quality of the patient's support. The GLM platform for Treatment.com AI, by supporting healthcare professionals, allows the inclusion of disadvantaged communities. To learn more about treatment products and services: www.treatment.com Or email: info@treatment.com

Article content

Advertising 3

Article content

About Rocket Doctor Inc.

Rockket Doctor is a technology -based digital health platform that dismantles obstacles that limit access to comprehensive and cost -effective health care. Our royal program provides doctors with tools to operate successful practices in the virtual and virtual personal care models, which allows them to provide care for patients in remote societies, especially those in rural and northern societies throughout Canada and on a city in the United States. Take advantage of the large language models, AI/ML and wireless medical devices, Rocket Doctor blocks the gap from health care, linking patients to fair and accessible virtual health care services regardless of age, location or financial situation. This includes patients with potential stigma such as drug use, mental health, etc.

To learn more about the Doctor Rocket platform and services, please visit www.rockteteutor.io
(we)
www.rockteteutor.ca
(Canada) or email Media@rockteTdoctor.io.

Advertising 4

Article content

For additional information, contact:

Dr. Aamam Hamza, CEO

ehamza@treatment.com

For media inquiries, call: Media@treatment.com

Call: +1 (612) 788-8900 / Toll-Free usa / Canada: +1 (888) 788-8955
Warning data

This news statement contains aspecting data based on Treatment.com expectations, estimates and expectations regarding its business and the economic environment in which it works, including in implementation of the contact initiative for shareholders and its timing. These phrases or aspiration information may relate to the completion of the Rockting Doctor's California Medicaid treatment and the expected benefits of a doctorate missile in this transaction and other factors or information. Although Treatment.com believes that the expectations expressed in these aspecting data are based on reasonable assumptions, these data are not guarantees for future performance and include risks and suspicions that are difficult to control or predict. Therefore, the actual results and results may differ materially from that expression in these aspecting phrases, and readers should not depend on these phrases. These aspecting data speaks only from the date of its manufacture, and Treatment.com does not undertake any obligatory to publicly update to reflect new information or the occurrence of future events or circumstances unless this is required otherwise under the law.

Advertising 5

Article content

Financial information directed towards the future

This news statement also contains financial information directed towards the future and financial expectations (Collective, “Fofi”) on expected Docction Doctor revenues and the total margins of
Partnership with the California Care Plan, which is subject to the same assumptions and risks Factors, restrictions and qualifications as shown in the above vertebrae. Fofi contained in This press statement was issued by the administration from the date of this news statement and was It provides for the purpose of providing readers with an understanding of importance like this Transactions for the work of the missile doctor, not an estimate of profitability or anything else Financial performance scale. Readers have been warned that Fofi contained in this news The version should not be used for purposes other than disclosure here. the The company relinquishes any intention or commitment to update or review any Fofi mentioned in this A press release, whether as a result of new information, future events, or otherwise, unless then Required by the applicable law. Fofi should not be used in this news statement Other things other than to reveal it here.

Canadian stock exchange does not accept the responsibility or accuracy of this version.


Article content

Comments are closed, but trackbacks and pingbacks are open.